In STZ/HFD‐induced diabetic mice, Fuc‐S treatment (100 or 200 mg/kg, 5 weeks) significantly improved glucose tolerance, lipid metabolism, and liver function, while reducing hepatic steatosis and serum ALT/AST levels. The gene discussed is GPT; the disease is fatty liver disease.